Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Fredun Pharmaceuticals Ltd
Your Vote -
Buy
25.00%
Hold
50.00%
Sell
25.00%
25.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Fredun Pharma - Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Saturday, 08
-
Fredun Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Fredun Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Fredun Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Fredun Pharma - Corrigendum I To The Notice Of Extraordinary General Meeting.
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Fredun Pharmaceuticals acquires Wagr.ai to Enter India’s Pet Tech Market
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Cessation
-
Fredun Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Fredun Pharma - Intimation Of Record Date For The Purpose Of EOGM Of The Company.
-
Fredun Pharma - Notice Of Book Closure For The Purpose Of Extra Ordinary General Meeting To Be Held On 22Nd October, 2025.
-
Fredun Pharma - Notice Convening Extra-Ordinary General Meeting ('EOGM') Of Fredun Pharmaceuticals Limited
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Fredun Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Fredun Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th September, 2025 Under Regulation 30 Of The Se
-
Fredun Pharma - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of Ind
-
Fredun Pharma has declared 7% Final dividend for the financial year March 2025
-
Fredun Pharma - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201
-
Fredun Pharma - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2024-25
-
Fredun Pharma - Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM)
-
Fredun Pharma - Submission Of The 38Th Annual Report Of Fredun Pharmaceuticals Limited For The Financial Year 2024-25.
-
Fredun Pharma - Reg. 34 (1) Annual Report.
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Fredun Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Key fundamentals
Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 307.8076 | 226.9811 | 182.9008 | 120.825 | 82.7105 |
| Liabilities | 307.8076 | 226.9811 | 182.9008 | 120.825 | 82.7105 |
| Equity | 4.7217 | 4.6992 | 4.5323 | 4.4326 | 3.9896 |
| Gross Profit | 50.5345 | 37.9823 | 27.7774 | 13.7953 | 9.1395 |
| Net Profit | 20.8076 | 15.6234 | 10.8066 | 6.3353 | 2.0146 |
| Cash From Operating Activities | -28.8833 | -0.4387 | -14.4088 | -2.3802 | 0.1699 |
| NPM(%) | 4.6 | 4.48 | 3.93 | 2.82 | 1.5 |
| Revenue | 451.7062 | 348.1562 | 274.6756 | 224.4595 | 133.8933 |
| Expenses | 401.1717 | 310.1739 | 246.8982 | 210.6642 | 124.7538 |
| ROE(%) | 15.89 | 11.93 | 8.25 | 4.84 | 1.53 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 890.45 | 4.68 | 80.06 | 878.42 | 301.39 | 0.57 |
| Lotus Eye Hospital and Institute Ltd | 130.35 | 4.99 | 423.13 | 3200.86 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 20.40 | 0.25 | 0.00 | 6646.05 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 669.60 | 1.48 | 0.00 | 3018.49 | -604.77 | 0.00 |
Company Info
Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.
Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers.
Read More
Parent Organisation
Fredun Pharmaceuticals Ltd.
Founded
08/06/1987
Managing Director
Dr.(Mrs.)Daulat N Medhora
NSE Symbol
FAQ
The current price of Fredun Pharmaceuticals Ltd is
The 52-week high for Fredun Pharmaceuticals Ltd is
The market capitalization of Fredun Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Fredun Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Fredun Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fredun Pharmaceuticals Ltd shares.
The CEO of Fredun Pharmaceuticals Ltd is Dr.(Mrs.)Daulat N Medhora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
